1. catalystcrusin
2. fullerfamily03
3. videoGURU
4. purpledeedee247
5. txrdr46
1.videoGURU 01/25/2018
Biogen reported Q4 Spinraza sales +34% Q/Q to $363 mln, above estimates (Biogen markets the drug for Ionis)
2.fullerfamily03 04/10/2018
Company has licensed IONIS-AZ6-2.5-LRx to AstraZeneca following advancement of the drug into development
3.indevur4 05/04/2018
Ionis Reports First Quarter 2018 Financial Results
4.purpledeedee247 05/11/2018
Confirms FDA Advisory Committee
5.catalystcrusin 10/17/2017
They need to pound the table on this.... Akcea Presents Data Demonstrating Significant Burden of Illness in Familial Chylomicronemia Syndrome {Link}
6.catalystcrusin 04/19/2018
Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of Antisense Drugs for Neurological Diseases
7.fullerfamily03 03/02/2018
IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease
8.purpledeedee247 04/20/2018
Biogen and Ionis expand strategic collaboration to develop drug candidates for a broad range of neurological…
9.fullerfamily03 04/24/2018
Biogen reported Q1 Spinraza sales flat Q/Q at $364 mln vs. ests near $380 mln
10.catalystcrusin 03/26/2018
Ionis and Akcea Present New Data from ATTR Amyloidosis Program at 16th International Symposium on Amyloidosis
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW